The trademark application AELYSA Bioassays was filed by Aminoverse B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on July 5, 2020, and it was registered by office on October 13, 2020 without any oppositions.
The application was filed in German (English was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Chemicals and biochemicals used in industry and science, with an organic base, in particular nucleic acids
Libraries with variants of nucleic acids, protein, biochemical catalysts, enzymes, enzyme preparations and enzyme complexes, antibodies, and bacteria cultures and/or bacteriological preparations
Kits used in industry and science, including immunity screening, blood tests and/or antibody tests, in particular Northern, Southern, and Western blots, and kits for the production of nucleic acids and/or nucleic acid libraries.
The mark was filed in class 5 with following description of goods:
Kits for medical and/or veterinary purposes, including immunity screening, blood tests and/or antibody tests, in particular Northern, Southern, and Western blots, and kits for the production, detection and quantification of nucleic acids, antibodies and biological substances including vitamins
In-vitro diagnostic reagents for medical and veterinary use
Biotechnological preparations for medical and/or veterinary purposes, in particular nucleic acids, nucleic acid libraries, biochemical catalysts, antibodies, bacteria and bacteriological preparations, including enzymes, enzyme preparations and/or enzyme complexes.
The mark was filed in class 42 with following description of goods:
Services of a chemical/biochemical laboratory, including immunity screening, blood tests and/or antibody tests, in particular Northern, Southern, and Western blots
Diagnosis services in the field of genetics, including the identification of genes
Diagnosis services including conducting blood tests
Research and laboratory research relating to clinical trials, including for the purpose of drug approval
Research relating to genomics, proteomics and pharmacology
Agent screening for scientific research purposes, including preclinical research and trials for pharmaceutical development purposes
Research and development of new diagnostic goods and pharmaceutical services for others
Pharmaceutical research, in particular for preclinical trials, and services for clinical trials, research and assessment.